Tag: Stents
Thrombosis Odds Up With Bioresorbable Vascular Scaffolds
BVSs linked to increased risk of MI, target lesion revascularization and failure versus metallic stents
High Platelet Reactivity Tied to Ischemic, Bleeding Outcomes
Findings based on two-year follow-up after drug-eluting stent implantation
Sildenafil-Coated Stent May Help Prevent Clots, Stenosis
In animal study, sildenafil showed potential in reducing both restenosis and blood clot formation
Embolic Protection Device Useful Post Carotid Artery Stenting
Reduced risks for in-hospital stroke or death, major stroke or death, and stroke in carotid stenosis
Risk Up for Triple Tx Versus DAPT in DES Implantation With A-Fib
Findings for patients with atrial fibrillation who underwent PCI with drug-eluting stents
Target-Vessel Failure Rate Similar for Scaffold, Stent in PCI
Increased two-year event rate of definite or probable device thrombosis for scaffold versus stent group
DAPT Cessation Patterns Vary With Diabetes Status After PCI
Risk of major adverse cardiovascular events up for DAPT disruption, regardless of diabetes status
Operator Experience Impacts Prognosis for Left Main PCI
Short-, long-term prognosis up for more experienced operators in left main coronary artery PCI
Achieving Optimal Medical Tx Before PCI Beneficial in CAD
Significant reduction in subsequent cardiac events for patients achieving OMT before stent implantation
Survival, QOL, CV Event Rate No Better With Drug-Eluting Stents
But, the drug-eluting devices do lead to fewer repeat revascularizations
